Konservative Therapie

  • W. Rösch
Chapter

Zusammenfassung

Refluxsymptome, insbesondere das Leitsymptom Sodbrennen, sind der Mehrzahl der Bevölkerung bekannt: Etwa 18% haben im Laufe eines Jahres mit entsprechenden Beschwerden zu tun und lassen sich, ohne den Arzt aufzusuchen, in der Apotheke oder Drogerie mit rezeptfreien Medikamenten gegen Säurebeschwerden versorgen. Nach den Untersuchungen von Graham et al. [7] kann man davon ausgehen, daß bei einer Person, die öfter als 6mal pro Woche wegen Refluxbeschwerden zu einem Antazidum greifen muß, eine endoskopisch verifizierbare Refluxösophagitis vorliegt. Sontag [29] spricht, was die gastroösophageale Refluxkrankheit anlangt, von einem Eisbergkonzept, wobei die überwiegende Mehrzahl der Patienten nur geringe oder sporadische Symptome aufweist („telephone refluxers“). Einer Gallup-Umfrage zufolge sind dies 44% der erwachsenen Bevölkerung der USA. Bei den „office refluxers“, die wegen chronischer Symptome den Arzt aufsuchen, weisen 40–50% bei der Inspektion der Speiseröhre erosive oder ulzeröse Schleimhautdefekte auf, so daß von einer Prävalenz der Refluxösophagitis von 2–5% in der Bevölkerung auszugehen ist.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Armstrong D, Monnier P, Nicolet M, Blum AL, Savary M (1991) Endoscopic assessment of oesophagitis. Gullet 1: 63–67Google Scholar
  2. 2.
    Bell NJV, Hunt RH (1992) Role of gastric acid suppression in the treatment of gastroesophageal reflux disease. Gut 32: 118–124CrossRefGoogle Scholar
  3. 3.
    Bianchi Porro G, Pace F, Sangaletti O (1990) Pattern of acid reflux in patients with reflux esophagitis resistant to HZ receptor antagonists. Scand J Gastroenterol 25: 810–814CrossRefGoogle Scholar
  4. 4.
    Chiba N, De Gara CJ, Burget DW, Wilkinson J, Hunt RH (1993) Rapidity of healing in GERD: a comparison of different drug classes by meta-analysis. Gastroenterology 104 [Suppl]: A53Google Scholar
  5. 5.
    Dent J, Yeomans ND, Mackinnon M, Reed W, Narielvala FM, Hetzel DJ (1994) Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled couble blind trial of their efficacy and safety. Gut 35: 590–598Google Scholar
  6. 6.
    Deschner WK, Benjamin SB (1989) Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 84: 1–5PubMedGoogle Scholar
  7. 7.
    Graham DY, Smith JL, Patterson DJ (1983) Why do apparently healthy people use antacid tablets? Am J Gastroenterol 78: 257–260PubMedGoogle Scholar
  8. 8.
    Hillman AL (1994) Economic analysis of alternative treatments for persistent gastrooesophageal reflux disease. Scand J Gastroenterol 29 [Suppl 201]: 98–102CrossRefGoogle Scholar
  9. 9.
    Hogan WJ (1990) Gastroesophageal reflux disease: An update on management. J Clin Gastroentero112 [Supp12]: 821–828Google Scholar
  10. 10.
    Inauen W, Emde C, Weber B et al. (1993) Effects of ranitidine and cisapride of acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Gut 34: 1025–1031PubMedCrossRefGoogle Scholar
  11. 11.
    Irwin RS, Zawacki JK, Curley FJ, French CL, Hoffman PJ (1989) Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am Rev Respir Dis 140: 1294–1300PubMedGoogle Scholar
  12. 12.
    Joelsson B, Johnsson F (1989) Heartburn–the acid test. Gut 30: 1523–1525PubMedCrossRefGoogle Scholar
  13. 13.
    Koelz HR (1989): Treatment of reflux esophagitis with HZ blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Scand J Gastroenterol 24 [Suppl 156]: 25–36CrossRefGoogle Scholar
  14. 14.
    Lam HGT, Breumelhof R, van Berge Henegouwen GP, Smout AJP (1994) Temporal relationship between episodes on non-cardiac chest pain and abnormal oesophageal function. Gut 35: 733–736PubMedCrossRefGoogle Scholar
  15. 15.
    Lundell L (1994) Long-term treatment of gastro-esophageal reflux disease with omeprazole. Scand J Gastroenterol 29 [Suppl 201]: 74–78CrossRefGoogle Scholar
  16. 16.
    Marks RD, Richter JE, Rizzo J, Koehler RE, Spenney JG, Mills TP, Champion G (1994) Orneprazole versus HZ receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 106: 907–915PubMedGoogle Scholar
  17. 17.
    May B, Micklefield G, Schott D (1991) Osophagusmotilitätsstörungen, gastroösophagealer Reflux und obstruktive Atemwegserkrankungen. Pneumologie 45: 389–391PubMedGoogle Scholar
  18. 18.
    DeMeester TR, Bonavina L, Albertucci M (1986) Nissen fundoplicatio for gastro-esophageal reflux disease–evaluation of primary repair in loo consecutive patients. Ann Surg 204: 9–20PubMedCrossRefGoogle Scholar
  19. 19.
    Meier JH, McNally PR, Punja M, Freeman SR, Perry M, Spaulding HS (1994) Does omeprazole ( Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 39: 2127–2133PubMedCrossRefGoogle Scholar
  20. 20.
    Ollyo JB, Goners JJ, Froehlich F, Restellini A, Monnier P, Fontolliet C, Savary M (1990) L’endobrachy-oesophage régresse-t-il après traitement efficace du reflux gastro-oesophagien? Schweiz Med Wochenschr 120: 716–720PubMedGoogle Scholar
  21. 21.
    Pace F, Bianchi Porro G (1988) Medical treatment of reflux oesophagitis: review of traditional therapies and omeprazole. Ital J Gastroenterol 20 [Suppl]: 23–29Google Scholar
  22. 22.
    Paterson WG, Murat BW (1990) Combined ambulatory esophageal manometry and dual-probe pH-metry in evaluation of patients with chronic unexplained cough. Dig Dis Sci 39: 1117–1125CrossRefGoogle Scholar
  23. 23.
    Rösch W, Armstrong D, Blum AL (1993) Volkskrankheit Sodbrennen. Vom pathologischen Reflux zur Refluxösophagitis. Dt Ärztebl 90: 190–196Google Scholar
  24. 24.
    Savary M, Miller G (1977) Der Ösophagus. Handbuch und Atlas Gassmann, SolothurnGoogle Scholar
  25. 25.
    Schindlbeck NE, Ippisch H, Klauser AG, Müller-Lissner SA (1991) Which pH threshold is best in esophageal pH monitoring? Am J Gastroenterol 86: 1138–1141PubMedGoogle Scholar
  26. 26.
    Smart HL, Atkinson M (1990) Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid ( Gaviscon liquid) in the management of reflux oesophagitis. J Roy Soc Med 83: 554–555PubMedGoogle Scholar
  27. 27.
    Smith PM, Kerr GD, Cockel R et al. (1994) A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Gastroenterology 107: 1312–1318PubMedGoogle Scholar
  28. 28.
    Sontag SJ, O’Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R (1990) Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 99: 613–620PubMedGoogle Scholar
  29. 29.
    Sontag SJ (1993) Rolling review: gastro-oesophageal reflux disease. Aliment Pharmacol Ther 7: 293–313PubMedCrossRefGoogle Scholar
  30. 30.
    Spechler SJ and the Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 326: 786–792CrossRefGoogle Scholar
  31. 31.
    Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK (1994) Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344: 1533–1536PubMedCrossRefGoogle Scholar
  32. 32.
    Vigneri S, Termini R, Leandro G, Pantalena M, Savarino V, Badalamenti S (1993) Comparison between five long-term treatment options for reflux oesophagitis: a multicenter study (abstract). OESO, Paris, p 191Google Scholar
  33. 33.
    Zhu H, Pace F, Sangaletti O, Binachi Porro G (1993) Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 28: 235–238PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • W. Rösch

There are no affiliations available

Personalised recommendations